Skip to main content
Download PDF
Download ePub

Consumption of dietary fiber and APOA5 genetic variants in metabolic syndrome: baseline data from the Korean Medicine Daejeon Citizen Cohort Study

Nutrition & Metabolism volume 21, Article number: 19 (2024) Cite this article

Abstract

Background

Consumption of dietary fiber has been suggested as an important aspect of a healthy diet to reduce the risk of metabolic syndrome (MetS), including cardiovascular disease. The role of fiber intake in MetS might differ by individual genetic susceptibility. APOA5 encodes a regulator of plasma triglyceride levels, which impacts the related mechanisms of MetS. This study investigated the association between dietary fiber and the risk of MetS, assessing their associations according to APOA5 genetic variants.

Methods

A total of 1985 participants aged 30–55 years were included from a cross-sectional study based on the Korean Medicine Daejeon Citizen Cohort study at baseline (2017–2019). Dietary fiber intake was measured using a semiquantitative food frequency questionnaire. The APOA5 polymorphisms (rs2266788 A > G, rs662799 A > G, and rs651821 T > C) were genotyped using the Asia Precision Medicine Research Array. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (95% CIs).

Results

A higher consumption of dietary fiber was associated with a lower prevalence of MetS (P = 0.025). Among the components of MetS, an inverse association with dietary fiber was observed in increased waist circumference (OR, 95% CI = 0.60, 0.41–0.88, P for trend = 0.009) and elevated triglycerides (OR, 95% CI = 0.69, 0.50–0.96, P for trend = 0.012). Regarding the interaction with APOA5 genetic variants, a stronger association with dietary fiber intake was shown in G allele carriers of rs662799 than in A/A carriers (OR, 95% CI = 2.34, 1.59–3.44, P for interaction = 0.024) and in C allele carriers of rs651821 than in T/T carriers (OR, 95% CI = 2.35, 1.59–3.46, P for interaction = 0.027).

Conclusions

The findings of this study suggest that the benefits of dietary fiber on the risk of MetS could be modified by genetic variants of the APOA5 gene, providing a more effective strategy for preventing MetS.

Introduction

Dietary fiber has long been known to contribute to improving and maintaining a healthy life since noncommunicable diseases have been rapidly increasing [1]. According to the Codex Alimentarius, dietary fiber was defined as nondigestible carbohydrate polymers with ten or more monomeric units in the human digestive tract [1, 2]. Natural fiber is obtained from plant-based foods such as fruits, vegetables, legumes, and whole grains. Fiber is subclassified into insoluble (e.g., cellulose, hemicellulose, and lignin) and soluble fiber (e.g., pectin, β-glucan, gums, and mucilage), resistant starch, and prebiotics based on solubility. To maintain and deliver health benefits such as the reduced risk of obesity, diabetes, cardiovascular disease, and some types of cancer, an adequate intake of dietary fiber was suggested, and the daily recommended amounts of fiber intake differ by sex and age [1, 3]. The range of global recommended dietary fiber is from 25 to 38 g per day, which could be achieved through the consumption of a variety of plant-based foods, fruits, and vegetables [1]. In noncommunicable diseases, accumulating evidence has accounted for the role of dietary fiber in assessing the optimal diet strategy for metabolic disorders and its underlying mechanism, which includes modulating body weight, lipid reduction, glucose metabolism, blood pressure, and chronic inflammation [4].

Metabolic syndrome (MetS) refers to the concurrence of five components relevant to cardiovascular risk factors, including elevated waist circumference (WC), triglycerides (TG), peripheral blood pressure (BP), fasting blood glucose (FBG), and low high-density lipoprotein cholesterol (HDL-C), resulting in abdominal obesity, dyslipidemia, hypertension, and hyperglycemia [4, 5]. MetS increases the risk of cardiovascular disorders, type 2 diabetes mellitus, stroke, and several cancers [6, 7]. Habitual diet and lifestyle are important contributing factors to the development of MetS [8]. Researchers in numerous epidemiological studies have reported that a healthy high fiber diet is necessary to prevent the risk of MetS. In a recent systematic meta-analysis, the consumption of fiber was found to be associated with a lower likelihood of MetS, indicating a possible inverse association between dietary fiber intake and the risk of MetS [3, 9]. To understand the effect of fiber and prevent MetS, it is necessary to identify the interaction with genetic susceptibility that impacts the related mechanisms of MetS [10]. Nevertheless, there are limited studies that have examined the interactive effect between dietary fiber intake and specific genes based on metabolism related to MetS.

Among the genetic mutations affecting MetS, apolipoprotein A5 (APOA5) is one of the genes in the APOA1/C3/A4/A5 gene cluster at 11q23. The APOA5 gene is a component of lipoprotein fractions that encode a protein-coding gene linked to determining plasma triglyceride levels [11]. The APOA5 gene may have functions that modulate the activation of lipoprotein lipase, secretion of very low-density lipoprotein (VLDL) particles, and interaction of the low-density lipoprotein (LDL) receptor family, which are implicated in MetS and thereby lead to an increased risk of coronary artery disease [12,13,14]. Recently, genome-wide association studies (GWAS) reported common genetic variants of APOA5 for MetS susceptibility according to the GWAS catalog (www.ebi.ac.uk/gwas/) [15,16,17,18,19]. Among the single nucleotide polymorphisms (SNPs) in APOA5, the − 1131T > C variant (rs662799) in the promoter region was specifically associated with hyperglyceridemia and resulted in an increased risk of MetS, depending on the different populations [18]. In addition, a recent meta-analysis revealed the impact of the rs662799 variant on MetS [20]. A few studies have demonstrated the interactive effects of modifiable lifestyle factors, including smoking, alcohol consumption, and habitual diet, on nutrients in food (e.g., carbohydrates, fats, n-6 fatty acids, whole grains, legumes, and intake of red and processed meat) according to different genotypes of the rs662799 variant in the APOA5 gene [21,22,23,24,25]. Given that a variety of environmental risk factors contribute to the occurrence of MetS, however, evidence of associations between the common variant of the APOA5 gene and risk factors for MetS, particularly dietary fiber, is still insufficient.

Taken together, this study considers the common SNPs (rs2266788, rs662799, and rs651821) in the APOA5 gene for MetS susceptibility identified by previous GWAS [15,16,17,18,19]. The aim of the study was to examine the association between dietary fiber intake and MetS along with its components and to explore how the role of dietary fiber in MetS could be modified by genetic variants of the APOA5 gene.

Materials and methods

Study population

This cross-sectional study was based on the Korean Medicine Daejeon Citizen Cohort (KDCC) study, which is a prospective cohort study in Korea aimed at assessing the causal relationships between lifestyle, genomics, and chronic diseases according to Korean medicine types. The KDCC study began in 2017 and is an ongoing prospective study of 2,000 adults aged 30–55 years living in Daejeon. The baseline survey was conducted from 2017 to 2019, with three follow-ups every 2 years between 2020 and 2025. The details of the KDCC study regarding the rationale, design, and baseline characteristics are described elsewhere [26]. Of the 2,000 subjects who completed a structured questionnaire and physical examination, one participant was excluded due to missing clinical information, and 14 participants were excluded because of implausible energy intake (< 500 kcal/day or > 5,000 kcal/day). Therefore, a total of 1,985 participants were included to analyze the association between dietary fiber intake and the risk of MetS. Additionally, individuals for whom a blood sample was not available to examine the individual’s DNA sequence were excluded from the association between genetic variants and their interactions with dietary fiber intake regarding MetS. For the genetic association, 1,980 participants for rs2266788, 1,981 participants for rs662799, and 1,967 participants for rs651821 were selected (Fig. 1). All participants provided written informed consent prior to participation, and the study protocol was approved by the Institutional Review Board at the Korea Institute of Oriental Medicine (IRB No. I-1703/002–002) and Dunsan Korean Medicine Hospital of Daejeon University (IRB No. DJDSKH-17-BM-12).

Fig. 1
figure 1

Flow diagram of analytical sample: the KDCC study

Full size image

Assessment of dietary fiber intake and covariates

All participants completed structured questionnaires regarding their sociodemographic factors, lifestyle, and dietary habits, which were administered by a trained interviewer. The participant’s habitual dietary intake was assessed using a semiquantitative food frequency questionnaire (SQFFQ) consisting of the usual frequencies of consumption classified into nine categories ranging from never or rare to three times per day and portion sizes consumed limited to three or four specified serving sizes [27]. Daily energy and fiber intake were calculated using CAN-PRO 5.0 (Computer Aided Nutritional Analysis Program, The Korean Nutrition Society, Seoul, Korea). The sociodemographic factors included age (continuous), sex, BMI (< 25 kg/m2 or ≥ 25 kg/m2), education level, occupation, and income. Health-related lifestyle factors included alcohol consumption, smoking status, and physical activity. Alcohol consumption was classified as none, ex-drinker, and current drinker. Smoking status was categorized as none, ex-smoker, and current smoker. Physical activity was assessed using the Korean version of the Global Physical Activity Questionnaire, and total units of metabolic equivalent task (MET-min/week) were calculated [28, 29]. Based on MET values, physical activity was subclassified into three groups (low, moderate, or high).

Diagnosis of metabolic syndrome

The National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) [30] with Korean-specific cutoffs of WC based on the guidelines of the Korean Obesity Society [31] was used to assess the diagnosis of MetS. Participants who met three or more of the following clinical criteria of 5 components were diagnosed with MetS: (1) abdominal obesity based on WC with cutoff points specific to South Koreans (≥ 90 cm in men and ≥ 85 cm in women); (2) TG levels (≥ 150 mg/dL or specific treatment for lipid abnormality); (3) BP (systolic BP, ≥ 130 mmHg and diastolic BP, ≥ 85 mmHg), or treatment for diagnosed hypertension; (4) FPG level (≥ 100 mg/dL or diagnosed type 2 diabetes); and (5) HDL-C level (< 40 mg/dL in men and < 50 mg/dL in women or drug treatment for lipid abnormality).

Genotyping

The APOA5 polymorphisms (rs2266788 A > G, rs662799 A > G, and rs651821 T > C) were selected from the genome-wide significant SNPs associated with MetS (Supplementary Table S1). Genomic DNA was extracted, and genotyping was performed using the Axiom™ Asia Precision Medicine Research Array (PMRA) chip (Thermo Fisher Scientific, Waltham, MA, USA), which includes over 750,000 SNPs containing 50,000 novel markers that can cover East and South Asian populations based on the human reference genome (GRCh37). Genotyping was successfully performed for 1,980 subjects for rs2266788, 1,981 subjects for rs662799, and 1,967 subjects for rs651821 (Fig. 1).

Statistical analyses

To assess dietary fiber consumption, energy-adjusted fiber intake was estimated using residual methods from a regression model with total caloric intake [32]. The energy-adjusted dietary fiber intake was divided into quartile groups to investigate the associations with the risk of MetS. Differences in sociodemographic and lifestyle factors, as well as MetS risk with its components, were described as the means and SD for continuous variables and frequencies and percentages for categorical variables across the quartile groups of dietary fiber intake. Linear regression was used to determine trends for BMI; the Jonckheere-Terpstra test was used for other continuous variables, and the Cochran-Mantel-Haenszel test was used for categorical variables as appropriate. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were estimated from multivariable logistic regression methods. The multivariable models were adjusted for a continuous variable (age) and categorical variables (sex, BMI, education level, occupation, income, alcohol consumption, smoking status, and physical activity) as described previously. The median intake of each quartile of fiber intake was used as a continuous variable to test for linear trends. In the analysis of APOA5 genetic variants, the χ2 test was used to assess Hardy-Weinberg equilibrium (HWE) of APOA5 polymorphisms (rs2266788, rs662799, and rs651821) in non-MetS groups. To determine gene-diet interactions, the dietary intake of fiber was divided into two groups (high and low) based on the median intake levels in the non-MetS groups. The likelihood ratio test comparing the main effects of the model including interaction terms was used to examine gene-diet interactions. For power analyses, sufficient power calculations were performed, assuming a gene-diet interaction effect of APOA5 genetic variants (OR = 2.3) based on the assumptions of genetic effects (OR = 2.2) and environmental effects (OR = 0.8) using Quanto version 1.2.4 with 80% at an α level of 0.05. SAS version 9.4 (SAS Institute Inc., Cary, NC, USA) was used to perform all statistical analyses. Statistical significance was defined as a two-sided p-value less than 0.05.

Results

General characteristics of the study population according to quartile group of dietary fiber intake

Table 1 shows the general characteristics of the study population, including sociodemographic factors, lifestyle, daily energy intake, MetS and its components, categorized into quartile groups of dietary fiber intake. Participants with higher fiber intake were relatively older than those with the lowest fiber intake (P < 0.001). The consumption of dietary fiber varied by sex, with higher fiber intake observed in females than in males (P < 0.001). Participants in the highest quartile had a lower BMI than those in the lowest quartile (P = 0.008). Across quartiles, participants with higher fiber intake were less likely to be current alcohol consumers, current smokers, or highly exercised (P < 0.001). However, daily total energy intake showed no significant association. Participants with higher fiber intake were less likely to have MetS risk (P = 0.045). Except for the FBG level, the mean WC (P < 0.001), TG (P < 0.001), systolic BP (P = 0.004), and diastolic BP (P < 0.001) were significantly higher in the lowest quartile of fiber consumers than in those with higher fiber intake; however, the HDL-C level was increased (P = 0.002).

Table 1 Baseline characteristics of the study population according to quartile group of dietary fiber intake, the KDCC study, 2017–2019
Full size table

Association between dietary fiber intake and risk of metabolic syndrome including components

Table 2 indicates the results of the multivariable model adjusted for covariables, showing the association between quartiles of fiber intake and the prevalence of MetS with its components. The findings demonstrate that individuals with higher fiber intake had a lower prevalence of increased WC (P = 0.005), elevated TG (P < 0.001), elevated BP (P = 0.007), and the risk of MetS (P = 0.025). Furthermore, higher fiber intake was significantly associated with lower ORs of MetS in individuals with elevated WC (OR, 95% CI = 0.60, 0.41–0.88, P for trend = 0.009) and elevated TG (OR, 95% CI = 0.69, 0.50–0.96, P for trend = 0.012) compared to those in the lowest quartile of fiber intake.

Table 2 Multivariable adjusted odds ratio (OR) and 95% confidence intervals (CI) of metabolic syndrome and its components by quartiles of dietary fiber intake
Full size table

Association between APOA5 genetic variants and metabolic syndrome risk

Table 3 presents the association between APOA5 genetic variants (rs2266788, rs662799, and rs651821) and MetS in the multivariable model. The minor allele frequencies of the three SNPs were common (MAF > 5%); rs2266788 (0.13), rs662799 (0.16), and rs651821 (0.18). These SNPs in the non-MetS groups were in HWE. In the multivariable model adjusted for covariates, those who were homozygous for rs662799 (OR, 95% CI = 2.59, 1.66–4.04, P < 0.001, G/G vs. A/A) and rs651821 (OR, 95% CI = 2.64, 1.69–4.13, P < 0.001, C/C vs. T/T) had an increased risk of MetS. When comparing the genetic models of APOA5 variants, the dominant models of the three variants of the APOA5 gene showed a significant association with MetS: carrying a G allele of rs2266788 (OR, 95% CI = 1.37, 1.03–1.81, P = 0.029, A/G + G/G vs. A/A), carrying a G allele of rs662799 (OR, 95% CI = 1.74, 1.31–2.31, P < 0.001, A/G + GG vs. A/A), and carrying a C allele of rs651821 (OR, 95% CI = 1.76, 1.32–2.33, P < 0.001, T/C + C/C vs. T/T). In the recessive model, those who carried a G allele of rs662799 (OR, 95% CI = 2.09, 1.37–3.17, P < 0.001, G/G vs. A/A + A/G) and a C allele of rs651821 (OR, 95% CI = 2.12, 1.39–3.22, P < 0.001, C/C vs. T/T + T/C) had an increased risk of MetS.

Table 3 Association between APOA5 genetic variants and metabolic syndrome risk
Full size table

Interaction between dietary fiber intake and APOA5 variants regarding metabolic syndrome risk

Table 4 demonstrates the interaction between dietary fiber consumption and MetS risk according to the genetic models of APOA5 variants. To investigate the gene-diet interaction, dietary fiber intake was divided into low and high groups based on the median levels in the non-MetS groups. When comparing the genetic models of each variant, low fiber intake while carrying a G allele of rs662799 showed an increased risk of MetS compared to that of individuals who were AA carriers in the dominant model, indicating a stronger interaction (OR, 95% CI = 2.34, 1.59–3.44, P for interaction = 0.024, A/G + G/G carriers with low fiber intake vs. A/A carriers with low fiber intake). Similarly, the significant association between dietary fiber intake and the risk of MetS was stronger among carriers of the rs651821 C allele than the T/T homozygous variant in the dominant model (OR, 95% CI = 2.35, 1.59–3.46, P for interaction = 0.027, T/C + C/C carriers with low fiber intake vs. T/T carriers with low fiber intake).

Table 4 Interaction between dietary fiber intake and APOA5 genetic variants regarding metabolic syndrome risk
Full size table

Discussion

The present study evaluated the association between dietary fiber consumption and the prevalence of MetS according to the genetic variants of the APOA5 gene among Korean adults. The findings indicated that higher dietary fiber intake showed a lower prevalence of MetS risk. Among the components of MetS, increased WC and elevated TG were associated with dietary fiber intake. Moreover, APOA5 rs662799 and rs651821 variants were found to modify the associations between dietary fiber intake and the risk of MetS, depending on genotype.

Previous epidemiological studies have shown conflicting results. This might be because of the different study populations (races), ages (adolescents or elderly adults), and dietary assessment methods, as Chen et al. mentioned in a meta-analysis on dietary fiber and MetS [9]. Furthermore, genetic heterogeneity or the gut microbiome in the putative processes underlying fiber and MetS may influence how dietary fiber affects the disease [33]. Recent evidence from a wide range of mechanistic studies relevant to MetS reveals an inverse association between dietary fiber intake and MetS, which is consistent with the findings of the present study [9]. MetS is caused by the co-occurrence of metabolic abnormalities, including obesity, insulin resistance, dyslipidemia, and hypertension. Plausible mechanisms of the dietary fiber effect on each component of MetS have been suggested. In the case of central obesity, appetite regulation and energy homeostasis may be linked to dietary fiber intake [34,35,36]. The insulin resistance and glucose tolerance associated with the modulation of glycemia and insulinemia-lowering properties could also be attributed to fiber consumption [37, 38]. The cholesterol-lowering effect of dietary fiber may result from the increase in the total excretion of fecal bile acids and the decrease in the glycemic response [39, 40]. Regarding the effect of dietary fiber on hypertension, several observational studies have shown an inverse association between them [41, 42], but the biological mechanism underlying this relationship remains unclear. In this study, we observed that high consumption of dietary fiber reduced the risk of increased WC and elevated TG levels. A meta-analysis of randomized controlled trials reported that dietary viscous fiber significantly affects decreased body weight and BMI, particularly WC [43]. Accumulating evidence suggests that increased intake of dietary fiber contributes to the regulation of energy metabolism by diluting excess energy, decreasing the absorption rate, and stimulating appetite suppression [44, 45]. On the other hand, evidence in the literature suggests that fiber intake may contribute to a hypocholesterolemic effect while not affecting hypotriglyceridemia [46, 47]. Nevertheless, the potential mechanisms suggest that metabolic responses affect the bioavailability of fiber based on the physicochemical characteristics of fiber in the lipid profile [48, 49]. Recently, several studies have suggested the benefit of dietary fiber consumption on gut bacteria, as high intake of fiber could modify gut microbiota populations, leading to a reduction in the risk of MetS [50, 51]. However, there are still insufficient studies to support and verify that fiber extensively mediates protective effects on the risk of MetS.

Despite the low plasma concentration of APOA5, its major function is to regulate plasma TG levels by enhancing TG-rich lipoprotein metabolism, inhibiting VLDL particle production, and accelerating the hepatic uptake of lipoprotein remnants [12]. The extracellular role of APOA5 is to facilitate plasma TG hydrolysis by stimulating lipoprotein lipase activity [52]. The plasma TG levels were significantly increased in transgenic APOA5 knockout mice, whereas the level of TG was decreased in mice overexpressing the APOA5 gene [11]. The intracellular role of the APOA5 gene is associated with cytoplasmic lipid droplets and has been proven to modulate TG storage in adipocytes [53]. Based on these physiological functions, recent study results have identified the link between the APOA5 gene and metabolic disorders, including obesity and MetS [54]. In this study, three common genetic variants in the APOA5 gene (rs2266788, rs662799, and rs651821) were associated with the risk of MetS. Several studies were conducted to explore the association between rs2266788 (3’-UTR variant) and TG levels conferring MetS risk across ethnic differences [54,55,56]. According to a longitudinal prospective cohort study in a Korean population, rs2266788 showed a significant correlation with MetS susceptibility [57]. Accumulating evidence has also determined that rs662799 genetic variants located upstream of the APOA5 promoter are linked to hypertriglyceridemia and increase the risk of MetS with its individual components [18, 20, 58, 59]. Additionally, the polymorphisms of rs662799 and rs651821 (5’-UTR variant) indicated significant associations with familial combined hyperlipidemia and lipid traits [60]. Zhou et al. reported that polygenetic variants at the 11q23 locus, including APOA5 rs662799, are linked to an increased 3GO risk of a condition called co-occurring hypertension, hyperglycemia, and dyslipidemia, which is composed of MetS [61]. The 3GO risk of the haplotype’s minor alleles was higher for the subjects who consumed less dietary fiber than it was for the major alleles, demonstrating the influence of interactions between the 11q23 haplotype and environmental factors [61]. The SNPs in the APOA1/C3/A4/A5 cluster showed interactions with environmental factors for the risk of MetS and its components [62]. Park et al. identified that carrying the minor alleles of rs2266788 and rs662799 increased the risk of TG levels showing interactions with specific nutrients (low fat, high carbohydrate, and low calcium), alcohol, and smoking status in men [24]. In terms of modifiable lifestyle factors, the incidence of MetS and its lipid-influencing components in the minor allele of the rs662799 variant had strong interactions with red and processed meat intake, a low-calorie diet with a Mediterranean pattern, physical activity, alcohol consumption, and smoking compared to the involvement of the major allele of this genetic variant [25, 63, 64]. In a recent study, Lim et al. demonstrated that altered gut microbes mediated by the APOA5 rs651821 variant were associated with the risk of MetS [65]. In this study, the risk of MetS was shown to be significantly increased in both the dominant and recessive genetic models of APOA5 variants. However, when comparing the interaction between each genetic model of APOA5 variants and dietary fiber intake, the impact on MetS susceptibility was different. In the dominant model of APOA5 variants, low dietary fiber intake was associated with an increased risk of MetS with a G allele of rs662799 and a C allele of rs651821 compared to high fiber intake. This finding indicates that the effects of dietary fiber on the risk of MetS were different for APOA5 rs662799 and rs651821 variants.

The possible mechanisms of how fiber regulates the risk of MetS by APOA5 rs662799 and rs651821 could be explained by the benefits of fiber on hyperlipidemia and hyperglycemia according to genetic variants. According to the evidence on the characteristics of fiber, such as a lower calorie content, bulking effect, and physicochemical properties (e.g., solubility and viscosity), fiber consumption delays gastric emptying in the stomach and reduces the absorption of lipids and carbohydrates in the intestine, resulting in lower TG levels [66, 67]. Given that APOA5 plays a role in the metabolism of TG-rich particles, high consumption of fiber may result in less activation of lipoprotein lipase in TG catabolism. High consumption of fiber may also be linked to reducing the chylomicron and hepatic synthesis of VLDL and its remnants [68]. Cicero et al. indicated that β-glucans, one of the bioactive compounds in fiber, contribute to the formation of a gelatinous layer in the intestinal lumen, leading to inhibition of lipid absorption and then lowering the effects of TG and cholesterol [69]. In addition, based on the fermentability of fiber, β-glucans impact bacterial metabolism and increase the diversity of gut microbiota linked to obesity and metabolic responses [70, 71]. The current study suggests the role of APOA5 genetic variants in determining the responses of MetS and obesity to dietary fiber related to plasma TG levels. However, our understanding of the molecular mechanisms of APOA5 gene expression that are responsible for the risk of MetS, including the antihyperlipidemic and antihyperglycemic benefits of fiber, is limited.

Several limitations should be considered when interpreting the results. Despite the inverse associations between dietary fiber consumption and the risk of MetS, the cross-sectional design of this study confers an inability to determine a temporal and causal inference. Moreover, owing to providing information on the prevalence of MetS and fiber intake in a population, it is difficult to assess the incidence or changes in MetS and long-term fiber intake over time. Dietary fiber consumption was collected using the SQFFQ based on habitual diet, but use of this tool includes potential recall bias, and the results cannot entirely reflect the participant’s usual intake. The energy adjusted for fiber by the residual method was used to assess and minimize measurement errors [32]. Although the current study observed interactions between dietary fiber intake and APOA5 variants for the risk of MetS, further study is needed to examine a sufficiently large population to improve statistical power and to carefully select relevant genetic markers to ensure the validity and reliability of the findings. Additionally, there might be potential and unmeasured confounding factors, which may affect the association between dietary fiber intake and MetS according to APOA5 genetic variants, although this study considered relevant confounders, including age, sex, sociodemographic, and lifestyle factors. Subsequent investigations utilizing large-scale studies involving representative population-based cohorts are necessary to substantiate the causal association across diverse ethnic backgrounds and geographic regions. A sufficiently substantial sample size has the capacity to detect meaningful genetic effects and gene-diet interactions with the requisite statistical power. To elucidate the interplay of fiber intake and APOA5 variants in relation to MetS risk, the exploration of additional pertinent genetic variants and the examination of the enduring effects of these interactions are imperative. Furthermore, the implementation of functional studies elucidating molecular mechanisms may significantly contribute to augmenting the generalizability of the identified interactions involving dietary fiber intake and MetS altering APOA5 variants.

Based on the findings of gene-diet interactions in this study, we found that metabolic processes (e.g., TG metabolism), absorption, and responsiveness, may exhibit variations contingent upon the individual’s APOA5 genetic variant. Consequently, nutritional strategies can be formulated based on these genetic considerations to reflect the individual’s specific requirements and sensitivities to dietary fiber. The enhancement of individual dietary practices is achievable through regulation of the quantity and proportion of dietary fiber influenced by the APOA5 genetic variant, which facilitates the provision of optimized nutritional guidelines aimed at promoting optimal nutrient metabolism, absorption, and overall lifestyle.

In conclusion, the response of MetS and its components to dietary fiber may be altered by individual genetic variants. Given that there were interactions between dietary fiber intake and APOA5 variants (rs662799 and rs651821) for the risk of MetS, we propose that low consumption of fiber may impact TG metabolism linked to MetS risk by altering the APOA5 gene. Furthermore, the understanding of how dietary fiber interacts with the risk of MetS and APOA5 genetic variants could provide more evidence to clarify the related molecular mechanisms and provide an effective strategy for preventing MetS.

Data availability

Due to ethical restrictions approved by the ethics committee of our institution, the data used in this study can be made available for research proposals by a request to Proof’s Publications Committee.

Abbreviations

APOA5:

Apolipoprotein A5

BMI:

Body mass index

BP:

Peripheral blood pressure

CI:

Confidence intervals

FBG:

Fasting blood glucose

GWAS:

Genome-wide association studies

HDL-C:

High-density lipoprotein cholesterol

HWE:

Hardy-Weinberg equilibrium

KDCC:

The Korean Medicine Daejeon Citizen Cohort

LDL:

Low-density lipoprotein

MAF:

Minor allele frequency

MET:

Metabolic equivalent task

MetS:

Metabolic syndrome

NCEP-ATP III:

The National Cholesterol Education Program-Adult Treatment Panel III

OR:

Odds ratios

SNP:

Single nucleotide polymorphism

SQFFQ:

Semiquantitative food frequency questionnaire

TG:

Triglycerides

VLDL:

Very low-density lipoprotein

WC:

Waist circumference

References

  1. McKeown NM, Fahey GC Jr., Slavin J, van der Kamp JW. Fibre intake for optimal health: how can healthcare professionals support people to reach dietary recommendations? BMJ 2022, 378:e054370.

  2. Evans CEL. Dietary fibre and cardiovascular health: a review of current evidence and policy. Proc Nutr Soc. 2020;79:61–7.

    Article  PubMed  Google Scholar 

  3. Wei B, Liu Y, Lin X, Fang Y, Cui J, Wan J. Dietary fiber intake and risk of metabolic syndrome: a meta-analysis of observational studies. Clin Nutr. 2018;37:1935–42.

    Article  CAS  PubMed  Google Scholar 

  4. Satija A, Hu FB. Cardiovascular benefits of dietary fiber. Curr Atheroscler Rep. 2012;14:505–14.

    Article  CAS  PubMed  Google Scholar 

  5. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–5.

    Article  CAS  PubMed  Google Scholar 

  6. Wilson PW, D’Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112:3066–72.

    Article  CAS  PubMed  Google Scholar 

  7. O’Neill S, O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16:1–12.

    Article  PubMed  Google Scholar 

  8. Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20:12.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Chen JP, Chen GC, Wang XP, Qin L, Bai Y. Dietary fiber and metabolic syndrome: a meta-analysis and review of related mechanisms. Nutrients 2017, 10.

  10. Abou Ziki MD, Mani A. Metabolic syndrome: genetic insights into disease pathogenesis. Curr Opin Lipidol. 2016;27:162–71.

    Article  CAS  PubMed  Google Scholar 

  11. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 2001;294:169–73.

    Article  CAS  PubMed  Google Scholar 

  12. Nilsson SK, Heeren J, Olivecrona G, Merkel M, Apolipoprotein. A-V; a potent triglyceride reducer. Atherosclerosis 2011, 219:15–21.

  13. Beckstead JA, Oda MN, Martin DD, Forte TM, Bielicki JK, Berger T et al. Structure-function studies of human apolipoprotein A-V: A regulator of plasma lipid homeostasis. Biochemistry. 2003, 42:9416-23.

  14. Nilsson SK, Lookene A, Beckstead JA, Gliemann J, Ryan RO, Olivecrona G. Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family. Biochemistry. 2007, 46:3896– 904.

  15. Kong S, Cho YS. Identification of female-specific genetic variants for metabolic syndrome and its component traits to improve the prediction of metabolic syndrome in females. BMC Med Genet. 2019;20:99.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Kraja AT, Vaidya D, Pankow JS, Goodarzi MO, Assimes TL, Kullo IJ, et al. A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium. Diabetes. 2011;60:1329–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Zhu Y, Zhang D, Zhou D, Li Z, Li Z, Fang L, et al. Susceptibility loci for metabolic syndrome and metabolic components identified in Han Chinese: a multi-stage genome-wide association study. J Cell Mol Med. 2017;21:1106–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Oh SW, Lee JE, Shin E, Kwon H, Choe EK, Choi SY, et al. Genome-wide association study of metabolic syndrome in Korean populations. PLoS ONE. 2020;15:e0227357.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Park JM, Park DH, Song Y, Kim JO, Choi JE, Kwon YJ, et al. Understanding the genetic architecture of the metabolically unhealthy normal weight and metabolically healthy obese phenotypes in a Korean population. Sci Rep. 2021;11:2279.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Xu C, Bai R, Zhang D, Li Z, Zhu H, Lai M, et al. Effects of APOA5 -1131T > C (rs662799) on fasting plasma lipids and risk of metabolic syndrome: evidence from a case-control study in China and a meta-analysis. PLoS ONE. 2013;8:e56216.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Lai CQ, Corella D, Demissie S, Cupples LA, Adiconis X, Zhu Y et al. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: The Framingham Heart Study. Circulation. 2006, 113:2062-70.

  22. Sánchez-Moreno C, Ordovás JM, Smith CE, Baraza JC, Lee YC, Garaulet M. APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean population. J Nutr. 2011;141:380–5.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Kang R, Kim M, Chae JS, Lee SH, Lee JH. Consumption of whole grains and legumes modulates the genetic effect of the APOA5 -1131 C variant on changes in triglyceride and apolipoprotein A-V concentrations in patients with impaired fasting glucose or newly diagnosed type 2 diabetes. Trials. 2014;15:100.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Park S, Kang S. Alcohol, carbohydrate, and calcium intakes and smoking interactions with APOA5 rs662799 and rs2266788 were associated with elevated plasma triglyceride concentrations in a cross-sectional study of Korean adults. J Acad Nutr Diet. 2020;120:1318–e291.

    Article  PubMed  Google Scholar 

  25. Choi WJ, Shin D. Interactions between red and processed meat consumption and APOA5 gene variants associated with the incidence of metabolic syndrome in Korean adults. Genes Nutr. 2022;17:5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Baek Y, Seo BN, Jeong K, Yoo H, Lee S. Lifestyle, genomic types and non-communicable diseases in Korea: a protocol for the Korean Medicine Daejeon Citizen Cohort study (KDCC). BMJ Open. 2020;10:e034499.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Kweon S, Kim Y, Jang MJ, Kim Y, Kim K, Choi S, et al. Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol. 2014;43:69–77.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Armstrong T, Bull F. Development of the world health organization global physical activity questionnaire (GPAQ). J Public Health. 2006;14:66–70.

    Article  Google Scholar 

  29. Lee J, Lee C, Min J, Kang DW, Kim JY, Yang HI, et al. Development of the Korean global physical activity questionnaire: reliability and validity study. Glob Health Promot. 2020;27:44–55.

    Article  PubMed  Google Scholar 

  30. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–52.

    Article  PubMed  Google Scholar 

  31. Lee S, Park HS, Kim SM, Kwon HS, Kim DY, Kim DJ, et al. Cut-off points of waist circumference for defining abdominal obesity in the Korean population. Korean J Obes. 2006;15:1–9.

    Google Scholar 

  32. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997;65:S1220–28. discussion 29S-31S.

    Article  Google Scholar 

  33. Kok CR, Rose D, Hutkins R. Predicting personalized responses to dietary fiber interventions: opportunities for modulation of the gut microbiome to improve health. Annu Rev Food Sci Technol. 2023;14:157–82.

    Article  CAS  PubMed  Google Scholar 

  34. Howarth NC, Saltzman E, Roberts SB. Dietary fiber and weight regulation. Nutr Rev. 2001;59:129–39.

    Article  CAS  PubMed  Google Scholar 

  35. Byrne CS, Chambers ES, Morrison DJ, Frost G. The role of short chain fatty acids in appetite regulation and energy homeostasis. Int J Obes (Lond). 2015;39:1331–8.

    Article  CAS  PubMed  Google Scholar 

  36. Chambers ES, Morrison DJ, Frost G. Control of appetite and energy intake by SCFA: what are the potential underlying mechanisms? Proc Nutr Soc. 2015;74:328–36.

    Article  CAS  PubMed  Google Scholar 

  37. Hallfrisch J, Facn, Behall KM. Mechanisms of the effects of grains on insulin and glucose responses. J Am Coll Nutr. 2000;19:s320–25.

    Article  Google Scholar 

  38. Delzenne NM, Cani PD. A place for dietary fibre in the management of the metabolic syndrome. Curr Opin Clin Nutr Metab Care. 2005;8:636–40.

    Article  PubMed  Google Scholar 

  39. Gunness P, Gidley MJ. Mechanisms underlying the cholesterol-lowering properties of soluble dietary fibre polysaccharides. Food Funct. 2010;1:149–55.

    Article  CAS  PubMed  Google Scholar 

  40. Galisteo M, Duarte J, Zarzuelo A. Effects of dietary fibers on disturbances clustered in the metabolic syndrome. J Nutr Biochem. 2008;19:71–84.

    Article  CAS  PubMed  Google Scholar 

  41. Whelton SP, Hyre AD, Pedersen B, Yi Y, Whelton PK, He J. Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. J Hypertens. 2005;23:475–81.

    Article  CAS  PubMed  Google Scholar 

  42. Lelong H, Blacher J, Baudry J, Adriouch S, Galan P, Fezeu L, et al. Individual and combined effects of dietary factors on risk of incident hypertension: prospective analysis from the NutriNet-Santé Cohort. Hypertension. 2017;70:712–20.

    Article  CAS  PubMed  Google Scholar 

  43. Jovanovski E, Mazhar N, Komishon A, Khayyat R, Li D, Blanco Mejia S, et al. Can dietary viscous fiber affect body weight independently of an energy-restrictive diet? A systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2020;111:471–85.

    Article  PubMed  Google Scholar 

  44. Kristensen M, Jensen MG. Dietary fibres in the regulation of appetite and food intake. Importance of viscosity. Appetite. 2011;56:65–70.

    Article  CAS  PubMed  Google Scholar 

  45. Lee I, Shi L, Webb DL, Hellström PM, Risérus U, Landberg R. Effects of whole-grain rye porridge with added inulin and wheat gluten on appetite, gut fermentation and postprandial glucose metabolism: a randomised, cross-over, breakfast study. Br J Nutr. 2016;116:2139–49.

    Article  CAS  PubMed  Google Scholar 

  46. Hollænder PL, Ross AB, Kristensen M. Whole-grain and blood lipid changes in apparently healthy adults: a systematic review and meta-analysis of randomized controlled studies. Am J Clin Nutr. 2015;102:556–72.

    Article  PubMed  Google Scholar 

  47. Zhu X, Sun X, Wang M, Zhang C, Cao Y, Mo G, et al. Quantitative assessment of the effects of beta-glucan consumption on serum lipid profile and glucose level in hypercholesterolemic subjects. Nutr Metab Cardiovasc Dis. 2015;25:714–23.

    Article  CAS  PubMed  Google Scholar 

  48. Chutkan R, Fahey G, Wright WL, McRorie J. Viscous versus nonviscous soluble fiber supplements: mechanisms and evidence for fiber-specific health benefits. J Am Acad Nurse Pract. 2012;24:476–87.

    Article  PubMed  Google Scholar 

  49. McRorie JW Jr., McKeown NM. Understanding the physics of functional fibers in the gastrointestinal tract: an evidence-based approach to resolving enduring misconceptions about insoluble and soluble fiber. J Acad Nutr Diet. 2017;117:251–64.

    Article  PubMed  Google Scholar 

  50. Hjorth MF, Astrup A. The role of viscous fiber for weight loss: food for thought and gut bacteria. Am J Clin Nutr. 2020;111:242–43.

    Article  PubMed  Google Scholar 

  51. Benítez-Páez A, Gómez D, Pulgar EM, Kjølbæk L, Brahe LK, Astrup A, Larsen L, et al. Impact of dietary fiber and fat on gut microbiota re-modeling and metabolic health. Trends Food Sci Technol. 2016;57:201–12.

    Article  Google Scholar 

  52. Merkel M, Loeffler B, Kluger M, Fabig N, Geppert G, Pennacchio LA, et al. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J Biol Chem. 2005;280:21553–60.

    Article  CAS  PubMed  Google Scholar 

  53. Su X, Kong Y, Peng DQ. New insights into apolipoprotein A5 in controlling lipoprotein metabolism in obesity and the metabolic syndrome patients. Lipids Health Dis. 2018;17:174.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Zheng XY, Zhao SP, Yan H. The role of apolipoprotein A5 in obesity and the metabolic syndrome. Biol Rev Camb Philos Soc. 2013;88:490–8.

    Article  PubMed  Google Scholar 

  55. Jasim AA, Al-Bustan SA, Al-Kandari W, Al-Serri A, AlAskar H. Sequence analysis of APOA5 among the Kuwaiti population identifies association of rs2072560, rs2266788, and rs662799 with TG and VLDL levels. Front Genet. 2018;9:112.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Masjoudi S, Sedaghati-Khayat B, Givi NJ, Bonab LNH, Azizi F, Daneshpour MS. Kernel machine SNP set analysis finds the association of BUD13, ZPR1, and APOA5 variants with metabolic syndrome in Tehran Cardio-metabolic Genetics Study. Sci Rep. 2021;11:10305.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Kang SW, Kim SK, Kim YS, Park MS. Risk prediction of the metabolic syndrome using TyG index and SNPs: a 10-year longitudinal prospective cohort study. Mol Cell Biochem. 2023;478:39–45.

    Article  CAS  PubMed  Google Scholar 

  58. Song KH, Cha S, Yu SG, Yu H, Oh SA, Kang NS. Association of apolipoprotein A5 gene– 1131T > C polymorphism with the risk of metabolic syndrome in Korean subjects. Biomed Res Int 2013, 2013:585134.

  59. Hechmi M, Dallali H, Gharbi M, Jmel H, Fassatoui M, Ben Halima Y et al. Association of rs662799 variant and APOA5 gene haplotypes with metabolic syndrome and its components: a meta-analysis in North Africa. Biosci Rep 2020, 40.

  60. Liu ZK, Hu M, Baum L, Thomas GN, Tomlinson B. Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese. Atherosclerosis. 2010;208:427–32.

    Article  CAS  PubMed  Google Scholar 

  61. Zhou JY, Park S. Associations of polygenetic variants at the 11q23 locus and their interactions with macronutrient intake for the risk of 3GO, a combination of hypertension, hyperglycemia, and dyslipidemia. J Pers Med 2021, 11.

  62. Wu Y, Yu Y, Zhao T, Wang S, Fu Y, Qi Y, et al. Interactions of environmental factors and APOA1-APOC3-APOA4-APOA5 gene cluster gene polymorphisms with metabolic syndrome. PLoS ONE. 2016;11:e0147946.

    Article  PubMed  PubMed Central  Google Scholar 

  63. de Luis Roman D, Primo D, Izaola O, Aller R. Association of the APOA-5 genetic variant rs662799 with metabolic changes after an intervention for 9 months with a low-calorie diet with a Mediterranean profile. Nutrients; 2022. p. 14.

  64. Son KY, Son HY, Chae J, Hwang J, Jang S, Yun JM, et al. Genetic association of APOA5 and APOE with metabolic syndrome and their interaction with health-related behavior in Korean men. Lipids Health Dis. 2015;14:105.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Lim MY, You HJ, Yoon HS, Kwon B, Lee JY, Lee S, et al. The effect of heritability and host genetics on the gut microbiota and metabolic syndrome. Gut. 2017;66:1031–38.

    Article  CAS  PubMed  Google Scholar 

  66. Rideout TC, Harding SV, Jones PJ, Fan MZ. Guar gum and similar soluble fibers in the regulation of cholesterol metabolism: current understandings and future research priorities. Vasc Health Risk Manag. 2008;4:1023–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Surampudi P, Enkhmaa B, Anuurad E, Berglund L. Lipid lowering with soluble dietary fiber. Curr Atheroscler Rep. 2016;18:75.

    Article  PubMed  Google Scholar 

  68. Fernandez ML. Soluble fiber and nondigestible carbohydrate effects on plasma lipids and cardiovascular risk. Curr Opin Lipidol. 2001;12:35–40.

    Article  CAS  PubMed  Google Scholar 

  69. Cicero AFG, Fogacci F, Veronesi M, Strocchi E, Grandi E, Rizzoli E, et al. A randomized placebo-controlled clinical trial to evaluate the medium-term effects of oat fibers on human health: the beta-glucan effects on lipid profile, glycemia and intestinal health (BELT) study. Nutrients; 2020. p. 12.

  70. den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54:2325–40.

    Article  Google Scholar 

  71. Wang Y, Ames NP, Tun HM, Tosh SM, Jones PJ, Khafipour E. High molecular weight barley β-glucan alters gut microbiota toward reduced cardiovascular disease risk. Front Microbiol. 2016;7:129.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank the efforts of those who contributed to this study.

Funding

This work was supported by the Development of Korean Medicine Original Technology for Preventive Treatment based on Integrative Big Data grant from the Korea Institute of Oriental Medicine (No. KSN1731121).

Author information

Authors and Affiliations

  1. Department of Food and Nutrition, Changwon National University, 20 Changwondaehak-ro, Uichang-gu, 51140, Changwon, Gyeongnam, South Korea

    Jimi Kim

  2. Korean Medicine Data Division, Korea Institute of Oriental Medicine, 1672 Yuseong-daero, Yuseong-gu, 34054, Daejeon, South Korea

    Younghwa Baek & Siwoo Lee

Authors
  1. Jimi Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Younghwa Baek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Siwoo Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conceptualization: JK, YB, and SL. Methodology: JK and SL. Investigation: JK, YB, and SL. Writing– Original Draft: JK and SL. Writing– Review & Editing: JK, YB, and SL. Supervision: JK and SL.

Corresponding author

Correspondence to Siwoo Lee.

Ethics declarations

Ethics approval and consent to participate

The study protocol was approved by the Institutional Review Board at the Korea Institute of Oriental Medicine (IRB No. I-1703/002–002) and Dunsan Korean Medicine Hospital of Daejeon University (IRB No. DJDSKH-17-BM-12). All participants provided written informed consent.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, J., Baek, Y. & Lee, S. Consumption of dietary fiber and APOA5 genetic variants in metabolic syndrome: baseline data from the Korean Medicine Daejeon Citizen Cohort Study. Nutr Metab (Lond) 21, 19 (2024). https://doi.org/10.1186/s12986-024-00793-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12986-024-00793-0

Keywords

Nutrition & Metabolism

ISSN: 1743-7075

Contact us